$ACUR
ACURA PHARMACEUTICALS, INC Stock $acur

$acur Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000114420416098297 Filed on May 02, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$224.0K	$5.357M
YoY Change	-95.82%	12654.76%
Cost Of Revenue	$100.0K	$255.0K
YoY Change	-60.78%	-15.0%
Gross Profit	$120.0K	$5.102M
YoY Change	-97.65%	-2077.52%
Gross Profit Margin	53.57%	95.24%
Selling, General & Admin	$2.246M	$2.297M
YoY Change	-2.22%	1.68%
% of Gross Profit	1871.67%	45.02%
Research & Development	$1.014M	$964.0K
YoY Change	5.19%	-32.96%
% of Gross Profit	845.0%	18.89%
Depreciation & Amortization	$34.00K	$30.00K
YoY Change	13.33%	0.0%
% of Gross Profit	28.33%	0.59%
Operating Expenses	$3.260M	$3.261M
YoY Change	-0.03%	-15.69%
Operating Profit	-$3.138M	$1.512M
YoY Change	-307.54%	-139.52%
Interest Expense	$249.0K	$308.0K
YoY Change	-19.16%	2.33%
% of Operating Profit		20.37%
Other Income/Expense, Net	-$246.0K	-$273.0K
YoY Change	-9.89%	4.2%
Pretax Income	-$3.384M	$1.239M
YoY Change	-373.12%	-130.31%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$3.384M	$1.239M
YoY Change	-373.12%	-130.31%
Net Earnings / Revenue	-1510.71%	23.13%
Basic Earnings Per Share	-$0.28	$0.13
Diluted Earnings Per Share	-$0.28	$0.13
COMMON SHARES
Basic Shares Outstanding	11.84M shares	9.793M shares
Diluted Shares Outstanding	11.84M shares	49.35M shares

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.97M	$14.21M
YoY Change	-22.8%	-36.81%
Cash & Equivalents	$782.0K	$3.821M
Short-Term Investments	$7.690M	$10.39M
Other Short-Term Assets	$300.0K	$310.0K
YoY Change	-3.23%	-65.93%
Inventory	$200.0K	$280.0K
Prepaid Expenses
Receivables	$140.0K	$90.00K
Other Receivables	$30.00K	$60.00K
Total Short-Term Assets	$11.63M	$14.96M
YoY Change	-22.26%	-36.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.030M	$970.0K
YoY Change	6.19%	2.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$180.0K	$150.0K
YoY Change	20.0%	-31.82%
Total Long-Term Assets	$2.790M	$2.910M
YoY Change	-4.12%	149.14%
TOTAL ASSETS
Total Short-Term Assets	$11.63M	$14.96M
Total Long-Term Assets	$2.790M	$2.910M
Total Assets	$14.42M	$17.87M
YoY Change	-19.31%	-28.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$380.0K	$160.0K
YoY Change	137.5%	-67.55%
Accrued Expenses	$1.210M	$1.060M
YoY Change	14.15%	24.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.575M	$2.370M
YoY Change	8.65%
Total Short-Term Liabilities	$4.430M	$3.760M
YoY Change	17.82%	128.99%
LONG-TERM LIABILITIES
Long-Term Debt	$4.810M	$7.350M
YoY Change	-34.56%	-23.68%
Other Long-Term Liabilities	$430.0K	$240.0K
YoY Change	79.17%	380.0%
Total Long-Term Liabilities	$5.240M	$7.590M
YoY Change	-30.96%	-21.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.430M	$3.760M
Total Long-Term Liabilities	$5.240M	$7.590M
Total Liabilities	$9.670M	$11.35M
YoY Change	-14.8%	0.28%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.750M	$6.520M
YoY Change
Total Liabilities & Shareholders Equity	$14.42M	$17.87M
YoY Change	-19.31%	-28.12%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$3.384M	$1.239M
YoY Change	-373.12%	-130.31%
Depreciation, Depletion And Amortization	$34.00K	$30.00K
YoY Change	13.33%	0.0%
Cash From Operating Activities	-$1.920M	$2.170M
YoY Change	-188.48%	-172.82%
INVESTING ACTIVITIES
Capital Expenditures	$49.00K	$46.00K
YoY Change	6.52%	35.29%
Acquisitions
YoY Change
Other Investing Activities	$3.180M	$930.0K
YoY Change	241.94%	1450.0%
Cash From Investing Activities	$3.130M	$880.0K
YoY Change	255.68%	3284.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-410.0K	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-1.920M	2.170M
Cash From Investing Activities	3.130M	880.0K
Cash From Financing Activities	-410.0K	0.000
Net Change In Cash	800.0K	3.050M
YoY Change	-73.77%	-187.8%
FREE CASH FLOW
Cash From Operating Activities	-$1.920M	$2.170M
Capital Expenditures	$49.00K	$46.00K
Free Cash Flow	-$1.969M	$2.124M
YoY Change	-192.7%	-170.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	acur	Interest Expense Debt Discount InterestExpenseDebtDiscount	26000	USD
CY2015Q1	acur	Debt Instrument Cash Maintenance DebtInstrumentCashMaintenance	2500000	USD
CY2015Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	5000000	USD
CY2015Q1	acur	Interest Expense Debt Discount InterestExpenseDebtDiscount	31000	USD
CY2016Q1	us-gaap	Debt Issuance Costs DebtIssuanceCosts	14000	USD
CY2015Q1	us-gaap	Debt Issuance Costs DebtIssuanceCosts	17000	USD
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	209000	USD
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	260000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1911000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2741000	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10000000	USD
CY2013Q4	acur	Debt Default Long Term Debt Percentage DebtDefaultLongTermDebtPercentage	0.1335	pure
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2979000	USD
CY2013Q4	us-gaap	Secured Debt SecuredDebt	10000000	USD
CY2016Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	231000	USD
CY2016Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	50000	USD
CY2016Q1	acur	Debt Consulting Placement Fee DebtConsultingPlacementFee	100000	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	acur	Inventory Reserve Expense InventoryReserveExpense	70000	USD
CY2015Q1	acur	Inventory Reserve Expense InventoryReserveExpense	260000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	91000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	414000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	362000	USD
CY2016Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	167000	USD
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	193000	USD
CY2016Q1	acur	Debt Instrument Issuance Cost DebtInstrumentIssuanceCost	83000	USD
CY2015Q4	acur	Debt Instrument Issuance Cost DebtInstrumentIssuanceCost	97000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11834000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11834000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11801000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11801000	shares
CY2015Q1	us-gaap	Depreciation Depreciation	30000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0	pure
CY2015Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	60000	shares
CY2015Q1	acur	Additions To Debt Instrument Unamortized Discount AdditionsToDebtInstrumentUnamortizedDiscount	33000	USD
CY2016Q1	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	2500000	USD
CY2016Q1	acur	Cash Cash Equivalent And Marketable Securities CashCashEquivalentAndMarketableSecurities	8500000	USD
CY2016Q1	acur	Working Capital WorkingCapital	4700000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	11963000	shares
CY2016Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	9789000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	5000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	4000	shares
CY2016Q1	acur	Incremental Common Shares Attributable To Restricted Stock IncrementalCommonSharesAttributableToRestrictedStock	5000	shares
CY2015Q1	acur	Incremental Common Shares Attributable To Restricted Stock IncrementalCommonSharesAttributableToRestrictedStock	34000	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	33000	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	13000	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	716000	shares
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1324000	shares
CY2015Q1	us-gaap	Retail Related Inventory RetailRelatedInventory	260000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4000	USD
CY2015	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	52800000	USD
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	155200000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2320000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	112000	USD
CY2016Q1	acur	Share Based Compensation Expense Recognized In Operations ShareBasedCompensationExpenseRecognizedInOperations	150000	USD
CY2015Q1	acur	Share Based Compensation Expense Recognized In Operations ShareBasedCompensationExpenseRecognizedInOperations	151000	USD
CY2015	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2000000	USD
CY2016Q1	acur	Longterm Portion Of Accrued Interest LongtermPortionOfAccruedInterest	433000	USD
CY2015Q4	acur	Longterm Portion Of Accrued Interest LongtermPortionOfAccruedInterest	387000	USD
CY2016Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2575000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	70000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6000	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	591000	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	23800	USD
CY2016Q1	us-gaap	Depreciation Depreciation	34000	USD
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	7381000	USD
CY2014Q2	us-gaap	Retail Related Inventory RetailRelatedInventory	260000	USD
CY2015Q4	acur	Sales Returns Liability SalesReturnsLiability	205000	USD
CY2016Q1	acur	Sales Returns Liability SalesReturnsLiability	242000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	255000	USD
CY2015Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	314000	USD
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	8040000	USD
CY2016Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	7631000	USD
CY2015Q4	acur	Debt Instrument Issuance Costs DebtInstrumentIssuanceCosts	-97000	USD
CY2016Q1	acur	Debt Instrument Issuance Costs DebtInstrumentIssuanceCosts	-83000	USD
CY2015Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	0	USD
CY2016Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-24000	USD
	acur	Share Based Compensation Arrangement Share Based Payment Shares Reserved For Future Distribution ShareBasedCompensationArrangementShareBasedPaymentSharesReservedForFutureDistribution	2400	shares
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	100000	USD
CY2016Q1	acur	Agreement Termination Notice Description AgreementTerminationNoticeDescription	Egalet may terminate the Egalet Agreement for convenience on 120 days prior written notice, which termination may not occur prior to the second anniversary of Egalet’s launch of Oxaydo. Termination does not affect a party’s rights accrued prior thereto, but there are no stated payments in connection with termination other than payments of obligations previously accrued. For all terminations (but not expiration), the Egalet Agreement provides for the transition of development and marketing of Oxaydo from Egalet to us, including the conveyance by Egalet to us of the trademarks and all regulatory filings and approvals relating to Oxaydo, and for Egalet’s supply of Oxaydo for a transition period.
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2802000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2754000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1774000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1741000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	276000	USD
CY2016Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	7700000	USD
CY2016Q1	acur	Inventory Valuation Written Off Finished Goods InventoryValuationWrittenOffFinishedGoods	-64000	USD
CY2015Q1	acur	Inventory Valuation Written Off Finished Goods InventoryValuationWrittenOffFinishedGoods	0	USD
CY2015Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	260000	USD
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	167000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	101000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	10900000	USD
CY2016Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	15000	USD
CY2015Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	0	USD
CY2016Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	193000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	346000	USD
CY2016Q1	us-gaap	Inventory Gross InventoryGross	208000	USD
CY2015Q4	us-gaap	Inventory Gross InventoryGross	346000	USD
CY2016Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	6000	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	70000	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2015Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	260000	USD
CY2016Q1	acur	Inventory Reserve Expense Raw And Packagings InventoryReserveExpenseRawAndPackagings	0	USD
CY2015Q1	acur	Inventory Reserve Expense Raw And Packagings InventoryReserveExpenseRawAndPackagings	260000	USD
CY2016Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	576000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	171000	USD
CY2016Q1	acur	Other Accrued Taxes Current OtherAccruedTaxesCurrent	7000	USD
CY2015Q4	acur	Other Accrued Taxes Current OtherAccruedTaxesCurrent	6000	USD
CY2016Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	17000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	357000	USD
CY2015Q1	us-gaap	Revenues Revenues	5357000	USD
CY2015Q1	acur	Cost Of Sales Excluding Inventory Write Down CostOfSalesExcludingInventoryWriteDown	324000	USD
CY2015Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	5000000	USD
CY2016Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	150000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1014000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2246000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3138000	USD
CY2015Q1	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2485000	USD
CY2016Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7687000	USD
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	10837000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	140000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	83000	USD
CY2015Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	37000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-273000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-246000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3314000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1270000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9793000	shares
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	417000	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	175000	USD
CY2016Q1	us-gaap	Interest Payable Current InterestPayableCurrent	53000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2016Q1	acur	Sales Returns Liability Current SalesReturnsLiabilityCurrent	242000	USD
CY2015Q4	acur	Sales Returns Liability Current SalesReturnsLiabilityCurrent	205000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5430000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	9061000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1512000	USD
CY2016Q1	us-gaap	Royalty Revenue RoyaltyRevenue	17000	USD
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	107000	USD
CY2016Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
CY2016Q1	us-gaap	Revenues Revenues	224000	USD
CY2016Q1	acur	Cost Of Sales Excluding Inventory Write Down CostOfSalesExcludingInventoryWriteDown	102000	USD
CY2016Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015Q1	us-gaap	Inventory Write Down InventoryWriteDown	260000	USD
CY2016Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	27000	USD
CY2015Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	35000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	249000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	308000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3384000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1239000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-3384000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	1239000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	70000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	31000	USD
CY2016Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	100000	USD
CY2015Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	3362000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	3845000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-24000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	70000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	209000	USD
CY2016Q1	acur	Provision For Sales Returns ProvisionForSalesReturns	37000	USD
CY2015Q1	acur	Provision For Sales Returns ProvisionForSalesReturns	153000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3177000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	925000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3128000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	879000	USD
CY2016Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	409000	USD
CY2015Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2900000	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	18000	USD
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34000	USD
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3100000	USD
CY2016Q1	acur	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	0	USD
CY2015Q4	acur	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	400000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3047000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	774000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3821000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	110000	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30000	USD
CY2016Q1	acur	Provision To Reduce Inventory To Net Realizable Value ProvisionToReduceInventoryToNetRealizableValue	0	USD
CY2015Q1	acur	Provision To Reduce Inventory To Net Realizable Value ProvisionToReduceInventoryToNetRealizableValue	260000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	150000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	151000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	40000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	48000	USD
CY2016Q1	acur	Amortization Of Bond Premium In Marketable Securities AmortizationOfBondPremiumInMarketableSecurities	19000	USD
CY2015Q1	acur	Amortization Of Bond Premium In Marketable Securities AmortizationOfBondPremiumInMarketableSecurities	41000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-12000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-3000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-74000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	238000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-121000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-159000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-214000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	265000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-56000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	591000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	428000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-353000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1922000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2167000	USD
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	99000	USD
CY2015Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	51000	USD
CY2016Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0	USD
CY2015Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-409000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	797000	USD
CY2015Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	15000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	126000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	64000	USD
CY2016Q1	acur	Accrued Other Professional Fees Current AccruedOtherProfessionalFeesCurrent	206000	USD
CY2015Q4	acur	Accrued Other Professional Fees Current AccruedOtherProfessionalFeesCurrent	92000	USD
CY2016Q1	acur	Marketing Advertising And Promotion MarketingAdvertisingAndPromotion	56000	USD
CY2015Q4	acur	Marketing Advertising And Promotion MarketingAdvertisingAndPromotion	115000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.024	pure
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.92	pure
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016Q1	acur	Debt Instrument Classification Amount DebtInstrumentClassificationAmount	0	USD
CY2016Q1	acur	Additions To Debt Instrument Unamortized Discount AdditionsToDebtInstrumentUnamortizedDiscount	0	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	26000	USD
CY2016Q1	acur	Amortization Expense Of Debt Instrument Issuance Costs AmortizationExpenseOfDebtInstrumentIssuanceCosts	14000	USD

Files In Submission

Name	View Source	Status
0001144204-16-098297-index-headers.html	Edgar Link	pending
0001144204-16-098297-index.html	Edgar Link	pending
0001144204-16-098297.txt	Edgar Link	pending
0001144204-16-098297-xbrl.zip	Edgar Link	pending
acur-20160331.xml	Edgar Link	completed
acur-20160331.xsd	Edgar Link	pending
acur-20160331_cal.xml	Edgar Link	unprocessable
acur-20160331_def.xml	Edgar Link	unprocessable
acur-20160331_lab.xml	Edgar Link	unprocessable
acur-20160331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v437137_10q.htm	Edgar Link	pending
v437137_ex31-1.htm	Edgar Link	pending
v437137_ex31-2.htm	Edgar Link	pending
v437137_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACUR
ACURA PHARMACEUTICALS, INC Stock $acur

2016 Q1 Form 10-Q Financial Statement

#000114420416098297 Filed on May 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACUR ACURA PHARMACEUTICALS, INC Stock $acur

2016 Q1 Form 10-Q Financial Statement

#000114420416098297 Filed on May 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACUR
ACURA PHARMACEUTICALS, INC Stock $acur